What The Study Did:
This study examined how common and at what cost is the practice of so-called “clawbacks” for topical prescription drugs when an insured patient’s copayment exceeds the insurer’s cost for the drug.
To access the embargoed study:
Visit our For The Media website at this link
Joslyn Kirby, M.D., M.S., M.Ed., of the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, is the corresponding author.
Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-10/jn-sac100719.php
JAMA Network Media Relations